Proliferative inhibition of danxiongfang and its active ingredients on rat vascular smooth muscle cell and protective effect on the VSMC damage induced by hydrogen peroxide

Journal of Ethnopharmacology

Volumn 126, Issue 2, 2009, Pages 197-206

  Wu, Li ^a   Li, Xiaorong ^a   Li, Yuhang ^a   Wang, Lijuan ^a   Tang, Yu ^a   Xue, Ming ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Crytotanshinone; Danshensu; Danxiongfang; Ferulic acid; Hydroxyl free radical; Nitric oxide; Proliferation; SOD; Vascular smooth muscle cell

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHINESE DRUG; CRYPTOTANSHINONE; DANXIONGFANG; ENDOTHELIN 1; FERULIC ACID; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CELL COUNT; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG POTENTIATION; DRUG STRUCTURE; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FENTON REACTION; HYPERLIPIDEMIA; IN VITRO STUDY; NONHUMAN; PROTEIN CONTENT; RAT; SMOOTH MUSCLE FIBER; SPIN TRAPPING; STRUCTURE ANALYSIS; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIOXIDANTS; AORTA; CARDIOTONIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COUMARIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; ENDOTHELIN-1; HYDROGEN PEROXIDE; HYDROXYL RADICAL; LACTATES; MALE; MALONDIALDEHYDE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; PHENANTHRENES; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 70350303374     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.08.045     Document Type: Article

References (42)

1. Bradford M.M. A rapid and sensitive method for quantification of microgram quantities of protein using the principle of protein dye binding. Analytical Biochemistry 72 (1976) 248-254
2. Chen M.L., Shou Q.Y., Pan Y.M., Zhang J.B., Sang R., Guan M.W., and Wu B.Y. Inhibitive and protective effects of guanxinning tablets on platelet aggregation and vascular endothelium in qi stagnation and blood stasis rats. Chinese Journal of Clinical Pharmacology and Therapeutics 5 (2005) 586-589
3. Chen Y., Li X.R., Gao J., Tang Y., Wang M.M., and Xue M. Protective effect of dangxiongfang on brain in hypoxia mice. Traditional Chinese Drug Research & Clinical Pharmacology 19 (2008) 366-368
4. Don M.J., Shen C.C., Syu W.J., Ding Y.H., and Sun C.M. Cytotoxic and aromatic constituents from Salvia miltiorrhiza. Phytochemistry 67 (2006) 497-503
5. Gao Y.G., Song Y.M., Yang Y.Y., Tang J.X., and Liu W.F. Pharmacology of tanshinone. Acta Pharmaceutica Sinica 14 (1979) 75-82
6. 2 induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase. Arteriosclerosis, Thrombosis and Vascular Biology 17 (1997) 3588-3592
7. Hou Y.Zh., Yang J., and Zhao G.R. Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II. European Journal of Pharmacology 499 (2004) 85-90
8. Hou Y.Zh., Zhao G.R., and Yang J. Protective effect of Ligusticum chuanxiong and Angelica sinensis on endothelial cell damage induced by hydrogen peroxide. Life Sciences 75 (2004) 1775-1786
9. Hou Y.Zh., Zhao G.R., Yuan Y.J., Zhu G.G., and Hiltunen R. Inhibition of rat vascular smooth muscle cell proliferation by extract of Ligusticum chuanxiong and Angelica sinensis. Journal of Ethnopharmacology 100 (2005) 140-144
10. Kong D.Y. Chemical constituents of salvia miltiorrhiza (Danshen). Chinese Journal of Pharmaceuticals 20 (1989) 279-285
11. Li X.L., Li X.R., Wang L.J., Li Y.H., Xu Y.X., and Xue M. Simultaneous determination of danshensu, ferulic acid, cryptotanshinone and tanshinone IIA in rabbit plasma by HPLC and their pharmacokinetic application in danxiongfang. Journal of Pharmaceutical and Biomedical Analysis 44 (2007) 1106-1112
12. Li X.L., Li X.R., Wang L.J., Li Y.H., and Xue M. Simultaneous determination of danshensu, ferulic acid, cryptotanshinone and tanshinone IIA in danxiongfang prescription by HPLC. Chinese Traditional Patent Medicine 30 (2008) 77-80
13. Li X.R., Li X.L., Wang L.J., Li Y.H., Xu Y.X., and Xue M. Pharmacokinetic interaction of ferulic acid and danshensu, the hydrophilic principal components of danshen and chuanxiong. Chinese Pharmacological Bulletin 23 (2007) 968-972
14. 4 in mice. China Journal of Chinese Materia Medica 32 (2007) 2177-2181
15. Li X.R., Wang L.J., Li Y.H., Xu Y.X., Chen Y., Ruan J.X., and Xue M. Effect of danxiongfang on reducing serum lipids level in rat model with hyperlipidemia induced by high lipid diet. Chinese Journal of Experimental Traditional medical Formulae 14 (2008) 42-45
16. Lin R., Wang W.R., Liu J.T., et al. Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism. Journal of Ethnopharmacology 108 (2006) 217-222
17. Lu M.H., Chao C.F., Tsai S.H., Chen J.Y., and Chang L.T. Autocrine effects of endothelin on in vitro proliferation of vascular smooth muscle cells from spontaneously hypertensive and normotensive rats. Clinical Experiment Hypertension 28 (2006) 463-474
18. Muzykantov V.R. Targeting of superoxide dismutase and catalase to vascular endothelium. Journal of Controlled Release 71 (2001) 1-21
19. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
20. Ross R. Atherosclerosis: an inflammatory disease. New England Journal of Medicine 340 (1999) 115-126
21. Schwartz S.M., DeBlois D., and O'Brien E.R.M. The intima: soil for atherosclerosis and restenosis. Circulation Research 77 (1995) 445-465
22. Shi G.Y., Shi X.G., Gong Y.Ch., Jin H.F., Yu J.R., Chen F., and Zeng G.Zh. Determination of the level of platelet activation in hypertensive patients treated with Danxiong Tongmai Keli. Journal of Shanghai Second Medical University 10 (2004) 822
23. Skalli O. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. Journal of Cell Biology 103 (1986) 2787-2796
24. Song J.P., Sun D.W., and Xie H. HPLC fingerprinting of total Ligusticum chuanxiong. Journal of Heilongjiang Medicine 17 (2004) 161-163
25. Spitz D.R., and Oberley L.W. An assay for superoxide dismutase activity in mammalian tissue homogenates. Analytical Biochemistry 179 (1989) 8-18
26. Stridh H., Kimland M., Jones D.P., Orrenius S., and Hampton M.B. Cytochrome c release and caspase activation in hydrogen peroxide- and tributyltin-induced apoptosis. FEBS Letters 429 (1998) 351-355
27. Takahashi S., and Abe T. Substrate-dependence of reduction of MTT: a tetrazolium dye differs in cultured astroglia and neurons. Neurochemical International 40 (2002) 440-448
28. Thiemermann C., and Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. European Journal of Pharmacology 182 (1990) 591-595
29. Uchiyama M., and Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry 86 (1978) 271-278
30. Wang H., Gao X.M., Zhang B.L., et al. Influence of different component of danshen on the proliferation in vessel smooth muscle cell. Tianjin Journal of Traditional Chinese Medicine 21 (2004) 231-233
31. Wang H., Gao X.M., and Zhang B.L. Tanshinone: an inhibitor of proliferation of vascular smooth muscle cells. Journal of Ethnopharmacology 99 (2005) 93-98
32. Wang L.J., Li X.R., Li Y.H., Xu Y.X., and Xue M. Study on antiinflammatory effect of danxiongfang prescription. Herald of Medicine 27 (2008) 1022-1024
33. Wang X.J., Yuan Sh.L., and Wang Ch.J. A preliminary study of the anti-cancer effect of tanshinone on hepatic carcinoma and its mechanism of action in mice. Chinese Journal of Oncology 18 (1996) 412-414
34. Wang W.R., Lin R., Peng N., and Han C.J. The protective effects of tanshinone IIA on vascular endothelial cells injury induced by hydrogen peroxide. Journal of Chinese Medicinal Materials 29 (2006) 53-55
35. Wang Zh.B., Castresana M.R., Detmer K., and Newman W.H. An IKB-α mutant inhibits cytokine gene expression and proliferation in human vascular smooth muscle cells. Journal of Surgery Research 102 (2002) 198-206
36. Xu R.S. Danshen: Biology and its Use (1990), Scientific Publishing Company, Beijing pp. 81-184
37. Zhou G.Y., Jiang W., Zhao Y., Ma G.G., Xin W.J., Yin J.J., and Zhao B.L. Sodium tanshinone IIA sulfonate mediates electron transfer reaction in rat heart mitochondria. Biochemical Pharmacology 65 (2003) 51-58
38. Yang G.M., Chai B.C., Wang T.S., and Pan Y. Studies on GC-MS and fingerprint of the components of Chuanxiong. Journal of Northwest Pharmaceutica 17 (2002) 147-150
39. Zhang X., and Tenne T.E. Inhibition of rat vascular smooth muscle cell proliferation by taurine and taurine analogues. Biochemical Pharmacology 57 (1999) 1331-1339
40. Zhou G.Y., Jiang W., Zhao Y., Ma G.G., Xin W.J., Yin J.J., and Zhao B.L. Sodium tanshinone IIA sulfonate mediates electron transfer reaction in rat heart mitochondria. Biochemical Pharmacology 65 (2003) 51-57
41. Zhu L., Shao Y.D., Dai H.J., et al. Effects of sodium β-3,4-dihydroxyphenyl lactate and β-phenyl lactic acid on prostacyclin and thromboxane A2 contents in plasma of rabbits after coronary artery occlusion. Acta Pharmaceutica Sinica 7 (1986) 533-536
42. Zhu Z.T., Li H.Q., Lu Y., Lou J.S., and Yao Zh. Inhibitive effect of puerarin on increased NO production by neonatal cardiomyocytes during hypoxia/reoxygenation injury. China Journal of Chinese Materia Medica 12 (2001) 856-859